Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the Effect of Triamcinolone in Vitiligo Patients
IRCT20251213068314N1Phase 2Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of triamcinolone in Vitiligo, sponsored by Shahid Beheshti University of Medical Sciences. Started Dec 2025; status: recruiting.
02
Drugs
triamcinolone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20251213068314N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251213068314N1.